Navigation Links
Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
Date:1/29/2009

RESULTS REVISE AND UPDATE DONG YING Q3 RESULTS REPORTED DECEMBER 10, 2008

NANTONG CITY, China, Jan. 29 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) is pleased to report financial highlights from the complete unaudited financial results of its wholly owned operating subsidiary, Dong Ying China, that have been consolidated into Sinobiopharma's financial statements for the six-month period ended November 30, 2008. The complete unaudited financial results for the period were filed with the SEC in Form Q10 on January 14, 2009 and available at www.edgar-online.com.

Financial highlights include:

  • Sales revenue increased to $1,902,376 for the six months ended November 30, 2008 from $583,748 in the corresponding period in 2007.

  • Gross profit increased to $1,223,180 (64% of sales revenue) from $116,009 (20% of revenue).

  • Increase in sales volume and the improvement in gross profit percentage are both due to growth in sales of Cisatracurium Besylate., a skeletal muscle relaxant. Sales of this product increased to $1,756,798 in the six months ended November 30, 2008 from $505,331 in the six months ended November 30, 2007.

  • Operating expenses for the six months ended November 30, 2008 were $2,115,788, as compared to $366,833 for the six months ended November 30, 2007. The most significant category of expenses was stock-based compensation of $972,375 in the six months ended November 30, 2008 compared to $nil in the same period in 2007, as the Company granted stock options to various directors, management, employees and consultants upon completing the reverse acquisition and effectively taking the Dongying companies public.
  • '/>"/>

SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
2. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
3. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
4. GEN Reports on Growing Reliance on Microfluidics Technology
5. Novozymes Reports Strong 2008 Results
6. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
7. Neogen Reports Best Quarter in Its 26-Year History
8. AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
9. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
10. GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research
11. The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 20, 2014 BlueInGreen, LLC ... Solutions, LLC (Pinnacle), and PCI, Inc., leading suppliers ... they have been selected to provide a new ... Arkansas Paul R. Noland Wastewater Treatment. The ... HyDOZ® gas dissolution technology, Pinnacle Ozone’s ...
(Date:11/21/2014)... , Nov. 20, 2014 Polaris Group ... dosed in its Phase 1 trial of ADI-PEG ... the treatment of malignant pleural mesothelioma (MPM) and ... conducting clinical trials on ADI-PEG 20, both as ... the treatment of several other indications, including breast ...
(Date:11/18/2014)... BRUNO, Calif. , Nov. 18, 2014 ... a platinum sponsor of the 10th Annual World Stem Cell ... regenerative medicine stakeholders. The 2014 World Stem Cell Summit will ... San Antonio, Texas . The ... discovery and development of lifesaving cures and therapies, convening the ...
(Date:11/18/2014)... 2014 Athena Signature Series: Turning Cancer ‘Off’ ... Emerson, a professor in the Regulatory Biology Laboratory at the ... discovery points to an “off switch” for drug resistance in ... her local research is making a global impact in the ... then join host Cheryl K. Goodman, CEO of Social Global ...
Breaking Biology Technology:City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3
... Type III von Willebrand Disease, a serious, hereditary ... bleeding disorder, found in ... Behring today,announced that Iran,s Ministry of Health and Medical Education ... on an exclusive,basis throughout Iran, beginning immediately. Haemate P is ...
... Path for ... New Treatments, WILMINGTON, Del. and ... ) today announced,that they will collaborate to help advance understanding of Alzheimer,s,disease ... cutting-edge brain imaging methods., The new alliance will focus on the ...
... TUSTIN, Calif., Dec. 19 AMDL, Inc., (Amex:,ADL), ... a,developer, manufacturer, and marketer of pharmaceutical, nutraceutical,diagnostic, consumer ... open,its first large-scale JPGreen Health and Personal Care ... by Jade to be converted,into a flagship JPGreen ...
Cached Biology Technology:CSL Behring Expands Into Middle East Market with Haemate(R) P 2CSL Behring Expands Into Middle East Market with Haemate(R) P 3AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease 2AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease 3AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease 4AMDL's First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China 2
(Date:11/3/2014)... A University of Colorado Cancer Center study ... Academy of Sciences describes the activity of a ... Interleukin 37 or IL-37. It has been known to ... in the adaptive immune system: IL-37 inhibits the ability ... antigens. , "Knowing this mechanism that underlies IL-37,s effect ...
(Date:11/3/2014)... low birth weight and preterm birth are linked to ... Findings published in the American College of Rheumatology (ACR) ... low birth weight and pre-term babies were not at ... adults. , According to the ACR, 27 million ... clinical OA. Symptoms of OA range from mild to ...
(Date:11/2/2014)... ORLEANS, LA (2 November 2014)—In support of a bold ... Bill & Melinda Gates Foundation today announced an award ... Malaria Vaccine Initiative (MVI) in building new vaccines that ... help realize the "accelerating to zero" agenda. Such vaccines ... what could be called an "immunological bed net." ...
Breaking Biology News(10 mins):PNAS: From HIV to cancer, IL-37 regulates immune system 2Preterm, low birth-weight babies may need new hips in adulthood 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4
... waste from nearby manufacturing plants flowed into the waters ... The harbor, which is contaminated with polychlorinated biphenyls (PCBs) ... Superfund cleanup sites. It,s also the site of ... Institution (WHOI) and their colleagues have been working to ...
... The rapid conversion of natural lands to cement-dominated urban centers ... new study involving 147 cities worldwide, surprisingly high numbers of ... environments to the tune of hundreds of bird species ... Contrary to conventional wisdom that cities are a wasteland for ...
... bags, an abundant source of litter on land and ... and other useful petroleum products, researchers report. The ... results in transportation fuels diesel, for example ... biodiesels. Other products, such as natural gas, naphtha (a ...
Cached Biology News:Solving an evolutionary puzzle 2Solving an evolutionary puzzle 3Solving an evolutionary puzzle 4Cities support more native biodiversity than previously thought 2Cities support more native biodiversity than previously thought 3Plastic shopping bags make a fine diesel fuel, researchers report 2
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
... The 2/3D Waver Shaker combines shaking and ... with a 330 x 330 mm stainless steel ... top incubator and cold room operation. The platform ... degree for a vigorous with action and rotation ...
Anti-DNA Polymerase a, Human Description: 50 l Research Focus: cancer & cell proliferation Storage: 4C Shipping Temperature: 4C...
... The Experion HighSens analysis kit for 25 ... to perform high-sensitivity RNA analysis (at picogram ... This kit includes 25 RNA HighSens microfluidic ... 2 x 20 microliters RNA HighSens stain, ...
Biology Products: